| __timestamp | Jazz Pharmaceuticals plc | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 1271353000 |
| Thursday, January 1, 2015 | 135253000 | 1620577000 |
| Friday, January 1, 2016 | 162297000 | 2052295000 |
| Sunday, January 1, 2017 | 198442000 | 2075142000 |
| Monday, January 1, 2018 | 226616000 | 2186100000 |
| Tuesday, January 1, 2019 | 299726000 | 3036600000 |
| Wednesday, January 1, 2020 | 335375000 | 2735000000 |
| Friday, January 1, 2021 | 505748000 | 2908100000 |
| Saturday, January 1, 2022 | 590453000 | 3592500000 |
| Sunday, January 1, 2023 | 849658000 | 4439000000 |
| Monday, January 1, 2024 | 5132000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc have been at the forefront of research and development (R&D) investments. From 2014 to 2023, Regeneron consistently outpaced Jazz, investing nearly 10 times more in R&D by 2023. Regeneron's R&D expenses grew from approximately $1.3 billion in 2014 to over $4.4 billion in 2023, marking a staggering 250% increase. Meanwhile, Jazz's R&D spending rose from about $85 million to $850 million, a tenfold increase. This significant investment underscores Regeneron's commitment to innovation, positioning it as a leader in the pharmaceutical industry. As these companies continue to push the boundaries of medical science, their R&D investments will likely play a crucial role in shaping the future of healthcare.
R&D Spending Showdown: Bristol-Myers Squibb Company vs Jazz Pharmaceuticals plc
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alnylam Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Regeneron Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How United Therapeutics Corporation and Jazz Pharmaceuticals plc Allocate Funds
R&D Insights: How Intra-Cellular Therapies, Inc. and Jazz Pharmaceuticals plc Allocate Funds
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Viking Therapeutics, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs CRISPR Therapeutics AG
Research and Development Investment: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.